Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-25 @ 2:40 AM
NCT ID:
NCT01960933
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years.
* Acute onset of chest pain of \< 12 hours' duration.
* ST-segment elevation ≥ 0.1 millivolt in ≥ 2 contiguous leads, signs of a true posterior infarction or documented newly developed left bundle branch block.
* Culprit lesion in a major native vessel.
* MVD (non-culprit vessels with angiographic stenosis \>50%)
* Successful primary PCI
Exclusion Criteria:
* Pregnancy.
* Known intolerance of acetylsalicylic acid, clopidogrel, heparin or contrast.
* Inability to understand information or to provide informed consent.
* Haemorrhagic diathesis or known coagulopathy.
* Stent thrombosis
* Significant left main stem stenosis
* Cardiogenic shock at admittance
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01960933
Study Brief:
Protocol Section:
NCT01960933